|
English
|
正體中文
|
简体中文
|
2823024
|
|
???header.visitor??? :
30212925
???header.onlineuser??? :
807
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"thye l s"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally) 1 View [10|25|50] records per page
臺大學術典藏 |
2020-05-25T07:35:20Z |
Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: Pharmacokinetics and recommended phase 2 dose
|
Venkatakrishnan K; Kim T.M; Chia-Chi Lin; Thye L.S; Chng W.J; Ma B; Chen M.H; Zhou X; Liu H; Kelly V; Kim W.S. |
國立成功大學 |
2020 |
Treatment of mantle cell lymphoma in Asia: A consensus paper from the Asian Lymphoma Study Group
|
Yoon, D.H.;Cao, J.;Chen, T.-Y.;Izutsu, K.;Kim, S.J.;Kwong, Y.L.;Lin, T.Y.;Thye, L.S.;Xu, B.;Yang, D.H.;Kim, W.S. |
Showing items 1-2 of 2 (1 Page(s) Totally) 1 View [10|25|50] records per page
|